Heerlen, NL, 13 Mar 2017 08:00 CET
Royal DSM, a global science-based company active in health, nutrition and materials, today announces that it intends to repurchase 2,900,000 ordinary shares, starting on 13 March 2017, in order to cover its commitments under existing management and personnel option plans (1,700,000) and shares for stock dividend as part of the final dividend 2016 (1,200,000). Based on the closing price of the DSM share on Euronext Amsterdam on 10 March 2017 this would be equivalent to approximately €185 million.
DSM has signed a Discretionary Management Agreement with the bank that will execute the repurchase. The repurchase price will be based on the daily VWAP (Volume Weighted Average Price). Volumes to be repurchased will be on average 5% of the daily trading volume on the open market, within a bandwidth of 2-8% per day. This share repurchase program is anticipated to continue into Q3 2017. The total number of shares to be repurchased under this program represents approximately 1.6% of ordinary shares issued.
In accordance with regulations DSM will inform the market about the progress made in the execution of this program through weekly press releases.
Senior Communications Manager
+31 45 578 2420
Vice-President Investor Relations
+31 45 578 2864